Cord Blood News 11.14 April 18, 2019 | |
| |
TOP STORYThe authors compared transplantation outcomes of 2963 patients with primary refractory or relapsed acute myeloid leukemia given cord blood transplantation, 10/10 HLA-matched UD, or 9/10 HLA-matched UD allo-allogeneic hematopoietic cell transplantation from 2004 to 2015 at EBMT-affiliated centers. [Blood Cancer J] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Researchers selected several metabolites to examine the relation between metabolites and stem cell functions. In addition, they investigated the ability of selected metabolites to induce rapid expansion of this cell population. [Sci Rep] Full Article In a Phase I dose-escalation trial at two dosing levels, the authors assessed the safety of intratracheal administration of a single-dose of human umbilical cord blood-derived mesenchymal stromal cells in 12 extremely low birth weight infants <28 weeks of gestation and <1000 g at birth at 5-14 days of life. [J Pediatr] Abstract Researchers investigated the role of human umbilical cord mesenchymal stem cell derived exosomes play on H9C2 cells apoptosis and possible mechanisms. [J Cell Biochem] Abstract Human Umbilical Cord‐Derived Scaffolds for Cartilage Tissue Engineering Scientists showed that human bone marrow‐derived‐MSCs in tissue‐derived scaffolds had an increased expression of chondrogenic markers compared with gelatin, whereas there were no significant differences between expression of hypertrophic and osteogenic markers between tissue and gelatin scaffolds. [J Biomed Mater Res A] Abstract Investigators compared angiogenesis of human mesenchymal stromal cell (hMSC) secretomes from adipose tissue, bone marrow, and umbilical cord Wharton’s jelly. hMSC secretomes were obtained under xenofree conditions and analyzed by liquid chromatography tandem mass spectrometry. [npj Regen Med] Full Article Subscribe to one of our other 19 science newsletters such as Hematopoiesis News & Cell Therapy News. | |
| |
REVIEWSOn the basis of in vitro and in vivo findings regarding the biological actions of extracellular vesicles (EVs) and experience in manufacturing biological stem cell therapeutics for routine use and clinical testing, the authors discuss strategies of manufacturing and quality control of umbilical cord-derived MSC-EVs. [Cytotherapy] Full Article Visit our reviews page to see a complete list of reviews in the cord blood research field. | |
| |
INDUSTRY NEWSVersiti Blood Research Institute Awarded Multi-Million Dollar REDS-IV Blood Study Contract Versiti Blood Research Institute has been awarded a seven-year federal contract valued at $7.4 million from the US Department of Health & Human Services to participate in the National Heart, Lung, and Blood Institute’s research program to protect the nation’s blood supply and improve the collection and use of blood products. [Versiti Blood Research Institute] Press Release Celularity, Inc. announced the company has entered into a long-term lease agreement to develop a 145,000 square-foot advanced cell manufacturing and research facility in Florham Park, New Jersey. [Celularity, Inc. (Business Wire, Inc.)] Press Release | |
| |
POLICY NEWSHow US-China Political Tensions Are Affecting Science In the latest twist, several US universities are expected to announce the actions they have taken against foreign scientists caught breaking rules concerning National Institutes of Health funding, according to comments made by agency director Francis Collins to the Senate Appropriations Committee. [Nature News] Editorial ‘Friendly’ Reviewers Rate Grant Applications More Highly Peer reviewers are four times more likely to give a grant application an “excellent” or “outstanding” score rather than a “poor” or “good” one when they are chosen by the grant’s applicants, an analysis of Swiss funding applications has found. [Nature News] Editorial Indian Scientists Launch Preprint Repository to Boost Research Quality Researchers in India will soon have their own preprint repository where they can post manuscripts from any discipline. The founders of IndiaRxiv hope it will improve the quality of science in the country. [Nature News] Editorial
| |
EVENTSNEW Blood Disorders: Models, Mechanisms and Therapies Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Researcher – Stem Cells and Erythropoiesis in MDS (Karolinska Institutet) Researcher Position – Cell Signaling (University of Tromsø) Assistant, Associate, or Full-Professor Positions – Cancer Research (Brown University) Postdoctoral Research Fellow – Functional Genomics (Justus Liebig University Giessen) Postdoctoral Fellows – Hematological Malignancies and Cancer Immunology (Fox Chase Cancer Center) Postdoctoral Position – Mechanobiology (The University of Texas Health Science Center at Houston) Postdoctoral Position – Hematopoietic Stem Cells (Washington University School of Medicine) Assistant Professor – Computational Biology/Stem Cell Biology (University of Illinois at Chicago) Faculty Positions – Cancer Research (Shenzhen University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Cord Blood News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|